Published in Int J Epidemiol on April 01, 2010
Comparing modelled predictions of neonatal mortality impacts using LiST with observed results of community-based intervention trials in South Asia. Int J Epidemiol (2010) 1.83
Neural tube defects. Annu Rev Neurosci (2014) 1.69
Epidemiology of neural tube defects. Saudi Med J (2014) 1.53
Awareness and uptake of measures for preventing CNS birth defects among mothers of affected children in a sub-Saharan African neurosurgeon's practice. Childs Nerv Syst (2015) 1.38
Economic burden of neural tube defects and impact of prevention with folic acid: a literature review. Eur J Pediatr (2011) 1.36
The role of nutrition in children's neurocognitive development, from pregnancy through childhood. Front Hum Neurosci (2013) 1.16
Folic acid in early pregnancy: a public health success story. FASEB J (2010) 1.16
Vitamin and mineral supplements: do we really need them? Int J Prev Med (2012) 1.14
Preconception care: nutritional risks and interventions. Reprod Health (2014) 1.06
Periconceptional folate deficiency and implications in neural tube defects. J Pregnancy (2012) 1.04
Born too soon: care before and between pregnancy to prevent preterm births: from evidence to action. Reprod Health (2013) 1.03
The prevention of schizophrenia--what can we learn from eco-epidemiology? Schizophr Bull (2010) 1.02
Limited access surgery for 360 degrees in-situ fusion in a dysraphic patient with high-grade spondylolisthesis. Eur Spine J (2011) 0.92
Maternal antenatal multiple micronutrient supplementation for long-term health benefits in children: a systematic review and meta-analysis. BMC Med (2016) 0.92
Essential interventions: implementation strategies and proposed packages of care. Reprod Health (2014) 0.91
Neural tube defects in Latin America and the impact of fortification: a literature review. Public Health Nutr (2013) 0.90
Describing the Prevalence of Neural Tube Defects Worldwide: A Systematic Literature Review. PLoS One (2016) 0.89
The Potential of Food Fortification to Add Micronutrients in Young Children and Women of Reproductive Age - Findings from a Cross-Sectional Survey in Abidjan, Côte d'Ivoire. PLoS One (2016) 0.88
Essential pre-pregnancy and pregnancy interventions for improved maternal, newborn and child health. Reprod Health (2014) 0.86
Epigenetic medicine and fetal alcohol spectrum disorders. Epigenomics (2013) 0.86
Women's lifestyle behaviors while trying to become pregnant: evidence supporting preconception guidance. Am J Obstet Gynecol (2011) 0.86
The effect of folic acid, protein energy and multiple micronutrient supplements in pregnancy on stillbirths. BMC Public Health (2011) 0.84
Public health interventions in midwifery: a systematic review of systematic reviews. BMC Public Health (2012) 0.83
Prevalence of congenital defects including selected neural tube defects in Nepal: results from a health survey. BMC Pediatr (2015) 0.83
The genomic origins of asthma. Thorax (2014) 0.83
Excess folate during adolescence suppresses thyroid function with permanent deficits in motivation and spatial memory. Genes Brain Behav (2011) 0.82
Novel single nucleotide polymorphisms in the superoxide dismutase 1 and 2 genes among children with myelomeningocele. Am J Obstet Gynecol (2013) 0.81
Malnutrition and disability: unexplored opportunities for collaboration. Paediatr Int Child Health (2014) 0.81
Clinical utility of folate-containing oral contraceptives. Int J Womens Health (2012) 0.80
Vitamin composition of ethnic foods commonly consumed in Europe. Food Nutr Res (2012) 0.79
Interventions to Improve Neonatal Health and Later Survival: An Overview of Systematic Reviews. EBioMedicine (2015) 0.79
Association of facilitated glucose transporter 2 gene variants with the myelomeningocele phenotype. Birth Defects Res A Clin Mol Teratol (2015) 0.79
Factors affecting the distribution of folate forms in the serum of elderly German adults. Eur J Nutr (2012) 0.79
Indian perspective on clinical aspects, usage, and guidelines of folic Acid. J Obstet Gynaecol India (2014) 0.78
Micronutrients Deficiency, a Hidden Hunger in Nepal: Prevalence, Causes, Consequences, and Solutions. Int Sch Res Notices (2015) 0.77
Birth prevalence of selected external structural birth defects at four hospitals in Dar es Salaam, Tanzania, 2011-2012. J Glob Health (2015) 0.77
Selected nutrients and their implications for health and disease across the lifespan: a roadmap. Nutrients (2014) 0.77
Health needs assessment for congenital anomalies in middle-income countries: Examining the case for neural tube defects in Brazil. J Community Genet (2013) 0.77
Deep sequencing study of the MTHFR gene to identify variants associated with myelomeningocele. Birth Defects Res A Clin Mol Teratol (2012) 0.77
Maternal consumption of non-staple food in the first trimester and risk of neural tube defects in offspring. Nutrients (2015) 0.77
Folate Metabolism and Human Reproduction. Geburtshilfe Frauenheilkd (2014) 0.77
Folic acid supplementation at lower doses increases oxidative stress resistance and longevity in Caenorhabditis elegans. Age (Dordr) (2015) 0.76
Genetic variations in the GLUT3 gene associated with myelomeningocele. Am J Obstet Gynecol (2014) 0.76
MTHFD1 polymorphism as maternal risk for neural tube defects: a meta-analysis. Neurol Sci (2014) 0.76
Effectiveness of Folic Acid Fortified Flour for Prevention of Neural Tube Defects in a High Risk Region. Nutrients (2016) 0.76
Folic acid protects against arsenic-mediated embryo toxicity by up-regulating the expression of Dvr1. Sci Rep (2015) 0.76
Decreased incidence of myelomeningocele at birth: effect of folic acid recommendations or prenatal diagnostics? Childs Nerv Syst (2011) 0.75
Myoinositol: The Bridge (PONTI) to Reach a Healthy Pregnancy. Int J Endocrinol (2017) 0.75
Folate and neural tube defects: The role of supplements and food fortification. Paediatr Child Health (2016) 0.75
Imaging the fetal central nervous system. Facts Views Vis Obgyn (2011) 0.75
Spectrum of Congenital Anomalies among Surgical Patients at a Tertiary Care Centre over 4 Years. Int J Pediatr (2017) 0.75
Prevention of neural tube defects by the fortification of flour with folic acid: a population-based retrospective study in Brazil. Bull World Health Organ (2015) 0.75
Replication and exploratory analysis of 24 candidate risk polymorphisms for neural tube defects. BMC Med Genet (2014) 0.75
Gene promoter DNA methylation patterns have a limited role in orchestrating transcriptional changes in the fetal liver in response to maternal folate depletion during pregnancy. Mol Nutr Food Res (2016) 0.75
Making birth defects 'preventable': pre-conceptional vitamin supplements and the politics of risk reduction. Stud Hist Philos Biol Biomed Sci (2013) 0.75
Genetic association of the glycine cleavage system genes and myelomeningocele. Birth Defects Res A Clin Mol Teratol (2016) 0.75
Primary prevention of neural tube defects in Brazil: insights into anencephaly. J Community Genet (2015) 0.75
An Update on Maternal Use of Antiepileptic Medications in Pregnancy and Neurodevelopment Outcomes. J Pediatr Genet (2015) 0.75
Global Burden of Neural Tube Defects, Risk Factors, and Prevention. Indian J Community Health (2014) 0.75
Organ-Specific Gene Expression Changes in the Fetal Liver and Placenta in Response to Maternal Folate Depletion. Nutrients (2016) 0.75
Knowledge of Health Professionals on Folic Acid Use and Their Prescribing Practice in Bahir Dar City Administration, Northwest Ethiopia: Cross-Sectional Study. PLoS One (2017) 0.75
Preconception interventions in infertile couples. J Educ Health Promot (2014) 0.75
Large -scale wheat flour folic acid fortification program increases plasma folate levels among women of reproductive age in urban Tanzania. PLoS One (2017) 0.75
Small renal size in newborns with spina bifida: possible causes. Clin Exp Nephrol (2013) 0.75
Congenital Malformations of the Central Nervous System in Rural Western Honduras: A 6-Year Report on Trends. World Neurosurg (2017) 0.75
Maternally Contributed Folate Receptor 1 Is Expressed in Ovarian Follicles and Contributes to Preimplantation Development. Front Cell Dev Biol (2017) 0.75
The development and evaluation of content validity of the Zambia Spina Bifida Functional Measure: Preliminary studies. Afr J Disabil (2017) 0.75
Grading quality of evidence and strength of recommendations. BMJ (2004) 26.08
Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet (1991) 17.95
Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA (2007) 7.93
Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med (1999) 6.27
Estimating the causes of 4 million neonatal deaths in the year 2000. Int J Epidemiol (2006) 5.50
Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA (2001) 5.33
Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002. Pediatrics (2005) 4.91
Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA (1989) 4.52
Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm Rep (1992) 4.22
Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Br Med J (Clin Res Ed) (1981) 4.12
Standards for CHERG reviews of intervention effects on child survival. Int J Epidemiol (2010) 3.90
Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA (1993) 3.71
Major central nervous system malformations in South Wales. II. Pregnancy factors, seasonal variation, and social class effects. Br J Prev Soc Med (1968) 3.50
Prevention of neural-tube defects. Lancet (1997) 3.11
A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomarkers Prev (2007) 2.91
Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA (1988) 2.74
Incidence of open neural tube defects in Nova Scotia after folic acid fortification. CMAJ (2002) 2.58
Prevalence of severe congenital heart disease after folic acid fortification of grain products: time trend analysis in Quebec, Canada. BMJ (2009) 2.50
Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology (1995) 2.48
Conclusions of a WHO Technical Consultation on folate and vitamin B12 deficiencies. Food Nutr Bull (2008) 2.35
Folic acid source, usual intake, and folate and vitamin B-12 status in US adults: National Health and Nutrition Examination Survey (NHANES) 2003-2006. Am J Clin Nutr (2009) 2.32
Decline of neural tube defects cases after a folic acid campaign in Nuevo León, México. Teratology (2002) 2.20
Colon cancer in Chile before and after the start of the flour fortification program with folic acid. Eur J Gastroenterol Hepatol (2009) 2.09
Association of neural tube defects and folic acid food fortification in Canada. Lancet (2002) 2.07
Socioeconomic inequalities in risk of congenital anomaly. Arch Dis Child (2000) 2.06
Incidence of neural tube defects in the least-developed area of India: a population-based study. Lancet (2005) 1.96
Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology (2002) 1.94
Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database Syst Rev (2001) 1.93
Socioeconomic status, neighborhood social conditions, and neural tube defects. Am J Public Health (1998) 1.85
Survival of infants with neural tube defects in the presence of folic acid fortification. Pediatrics (2006) 1.72
Decline in the prevalence of neural tube defects following folic acid fortification and its cost-benefit in South Africa. Birth Defects Res A Clin Mol Teratol (2008) 1.56
Dietary folate as a risk factor for neural-tube defects: evidence from a case-control study in Western Australia. Med J Aust (1989) 1.48
Hungarian cohort-controlled trial of periconceptional multivitamin supplementation shows a reduction in certain congenital abnormalities. Birth Defects Res A Clin Mol Teratol (2004) 1.47
Surveillance of neural tube defects in Israel: the effect of the recommendation for periconceptional folic acid. Isr Med Assoc J (2006) 1.44
Preconceptional folate supplementation and the risk of spontaneous preterm birth: a cohort study. PLoS Med (2009) 1.43
International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working? BMJ (2005) 1.39
Reduction of birth prevalence rates of neural tube defects after folic acid fortification in Chile. Am J Med Genet A (2005) 1.34
Trend in prevalence of neural tube defects in Quebec. Birth Defects Res A Clin Mol Teratol (2003) 1.33
Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2009) 1.30
Prevalence of neural tube defects in South Australia, 1966-91: effectiveness and impact of prenatal diagnosis. BMJ (1993) 1.24
Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Final report. Arch Gynecol Obstet (1994) 1.22
A comprehensive evaluation of food fortification with folic acid for the primary prevention of neural tube defects. BMC Pregnancy Childbirth (2004) 1.15
Neural tube defects: an analysis of neighbourhood- and individual-level socio-economic characteristics. Paediatr Perinat Epidemiol (2009) 1.14
Folic acid and the prevention of neural tube defects. Ann N Y Acad Sci (1993) 1.13
Contributions of total daily intake of folic acid to serum folate concentrations. JAMA (2008) 1.08
High frequency of neural-tube defects in North India. Lancet (1978) 1.04
A randomised trial of low dose folic acid to prevent neural tube defects. The Irish Vitamin Study Group. Arch Dis Child (1992) 1.02
Wheat flour fortification is unlikely to benefit the neediest in Guatemala. J Nutr (2007) 0.99
Unintended pregnancy rates among a US military population. Paediatr Perinat Epidemiol (2008) 0.98
Neural tube defects in Pondicherry. Indian J Pediatr (2005) 0.93
[Impact of folic acid fortification on women's nutritional status and on the prevalence of neural tube defects]. Arch Argent Pediatr (2008) 0.92
Shall we put the world on folate? Lancet (2009) 0.92
Effect of introduction of synchronized nasal intermittent positive-pressure ventilation in a neonatal intensive care unit on bronchopulmonary dysplasia and growth in preterm infants. Am J Perinatol (2006) 0.91
Early variable-flow nasal continuous positive airway pressure in infants < or =1000 grams at birth. J Perinatol (2006) 0.85
Trends in neural tube defects in Western Australia in Indigenous and non-Indigenous populations. Paediatr Perinat Epidemiol (2004) 0.85
Prevalence of neural tube defect pregnancies in England and Wales from 1964 to 2004. J Med Screen (2007) 0.85
Neural tube defects: is a decreasing prevalence associated with a decrease in severity? Eur J Obstet Gynecol Reprod Biol (2005) 0.82
4 million neonatal deaths: when? Where? Why? Lancet (2005) 28.92
Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet (2010) 26.48
Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet (2012) 25.96
Evidence-based, cost-effective interventions: how many newborn babies can we save? Lancet (2005) 18.87
What works? Interventions for maternal and child undernutrition and survival. Lancet (2008) 13.89
Countdown to 2015 decade report (2000-10): taking stock of maternal, newborn, and child survival. Lancet (2010) 12.15
National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet (2012) 10.21
Effect of expanded insecticide-treated bednet coverage on child survival in rural Kenya: a longitudinal study. Lancet (2007) 7.98
Stillbirths: Where? When? Why? How to make the data count? Lancet (2011) 5.40
Neonatal mortality levels for 193 countries in 2009 with trends since 1990: a systematic analysis of progress, projections, and priorities. PLoS Med (2011) 5.33
Causes of deaths in children younger than 5 years in China in 2008. Lancet (2010) 5.02
Gaps in policy-relevant information on burden of disease in children: a systematic review. Lancet (2005) 4.64
Improvement of perinatal and newborn care in rural Pakistan through community-based strategies: a cluster-randomised effectiveness trial. Lancet (2011) 4.42
The influence of distance and level of care on delivery place in rural Zambia: a study of linked national data in a geographic information system. PLoS Med (2011) 4.04
Implementing community-based perinatal care: results from a pilot study in rural Pakistan. Bull World Health Organ (2008) 3.99
Standards for CHERG reviews of intervention effects on child survival. Int J Epidemiol (2010) 3.90
Early treatment of childhood fevers with pre-packaged antimalarial drugs in the home reduces severe malaria morbidity in Burkina Faso. Trop Med Int Health (2003) 3.58
'Kangaroo mother care' to prevent neonatal deaths due to preterm birth complications. Int J Epidemiol (2010) 3.55
60 Million non-facility births: who can deliver in community settings to reduce intrapartum-related deaths? Int J Gynaecol Obstet (2009) 3.48
Effect of provision of daily zinc and iron with several micronutrients on growth and morbidity among young children in Pakistan: a cluster-randomised trial. Lancet (2013) 3.45
Setting priorities in global child health research investments: guidelines for implementation of CHNRI method. Croat Med J (2008) 3.42
30 years after Alma-Ata: has primary health care worked in countries? Lancet (2008) 3.40
Born too soon: the global epidemiology of 15 million preterm births. Reprod Health (2013) 3.32
Alma-Ata: Rebirth and Revision 6 Interventions to address maternal, newborn, and child survival: what difference can integrated primary health care strategies make? Lancet (2008) 3.32
3.6 million neonatal deaths--what is progressing and what is not? Semin Perinatol (2010) 3.26
Setting priorities in global child health research investments: assessment of principles and practice. Croat Med J (2007) 3.24
Feasibility and acceptability of artemisinin-based combination therapy for the home management of malaria in four African sites. Malar J (2008) 3.24
Iranian national thalassaemia screening programme. BMJ (2004) 3.22
Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet (2012) 2.98
Screening extended families for genetic hemoglobin disorders in Pakistan. N Engl J Med (2002) 2.94
Newborn survival: a multi-country analysis of a decade of change. Health Policy Plan (2012) 2.80
High ANC coverage and low skilled attendance in a rural Tanzanian district: a case for implementing a birth plan intervention. BMC Pregnancy Childbirth (2010) 2.76
Why are 4 million newborn babies dying each year? Lancet (2004) 2.50
Saving newborn lives in Asia and Africa: cost and impact of phased scale-up of interventions within the continuum of care. Health Policy Plan (2008) 2.48
Are the millennium development goals on target? BMJ (2010) 2.35
Linking families and facilities for care at birth: what works to avert intrapartum-related deaths? Int J Gynaecol Obstet (2009) 2.12
Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control. Parasit Vectors (2012) 2.08
Mathematical models in the evaluation of health programmes. Lancet (2011) 2.05
Strain characterization of natural sheep scrapie and comparison with BSE. J Gen Virol (2002) 2.04
Neonatal resuscitation and immediate newborn assessment and stimulation for the prevention of neonatal deaths: a systematic review, meta-analysis and Delphi estimation of mortality effect. BMC Public Health (2011) 1.95
The influence of HIV-1 exposure and infection on levels of passively acquired antibodies to measles virus in Zambian infants. Clin Infect Dis (2007) 1.89
Comparing modelled predictions of neonatal mortality impacts using LiST with observed results of community-based intervention trials in South Asia. Int J Epidemiol (2010) 1.83
Antenatal steroids in preterm labour for the prevention of neonatal deaths due to complications of preterm birth. Int J Epidemiol (2010) 1.81
Four million neonatal deaths: counting and attribution of cause of death. Paediatr Perinat Epidemiol (2008) 1.80
Care during labor and birth for the prevention of intrapartum-related neonatal deaths: a systematic review and Delphi estimation of mortality effect. BMC Public Health (2011) 1.77
Effectiveness of artemisinin-based combination therapy used in the context of home management of malaria: a report from three study sites in sub-Saharan Africa. Malar J (2008) 1.76
Tetanus toxoid immunization to reduce mortality from neonatal tetanus. Int J Epidemiol (2010) 1.73
Cost-effectiveness of strategies to improve the utilization and provision of maternal and newborn health care in low-income and lower-middle-income countries: a systematic review. BMC Pregnancy Childbirth (2014) 1.70
Recommendations for introducing genetics services in developing countries. Nat Rev Genet (2003) 1.70
Why are 4 million newborn babies dying every year? Lancet (2004) 1.69
Effect of geographical access to health facilities on child mortality in rural Ethiopia: a community based cross sectional study. PLoS One (2012) 1.68
Integrated community case management of fever in children under five using rapid diagnostic tests and respiratory rate counting: a multi-country cluster randomized trial. Am J Trop Med Hyg (2012) 1.66
Lives Saved Tool supplement detection and treatment of syphilis in pregnancy to reduce syphilis related stillbirths and neonatal mortality. BMC Public Health (2011) 1.64
Clean birth and postnatal care practices to reduce neonatal deaths from sepsis and tetanus: a systematic review and Delphi estimation of mortality effect. BMC Public Health (2011) 1.64
Maternal and perinatal health research priorities beyond 2015: an international survey and prioritization exercise. Reprod Health (2014) 1.61
Where is maternal and child health now? Lancet (2006) 1.58
Neonatal measles immunity in rural Kenya: the influence of HIV and placental malaria infections on placental transfer of antibodies and levels of antibody in maternal and cord serum samples. J Infect Dis (2005) 1.56
Making stillbirths count, making numbers talk - issues in data collection for stillbirths. BMC Pregnancy Childbirth (2009) 1.54
The effect of umbilical cord cleansing with chlorhexidine on omphalitis and neonatal mortality in community settings in developing countries: a meta-analysis. BMC Public Health (2013) 1.41
Integrated Management of Childhood Illnesses strategy: compliance with referral and follow-up recommendations in Gezira State, Sudan. Bull World Health Organ (2003) 1.38
Immunogenicity of standard-titer measles vaccine in HIV-1-infected and uninfected Zambian children: an observational study. J Infect Dis (2007) 1.38
Methodological issues in the assessment of antimalarial drug treatment: analysis of 13 studies in eight African countries from 2001 to 2004. Antimicrob Agents Chemother (2006) 1.36
Effect of case management on neonatal mortality due to sepsis and pneumonia. BMC Public Health (2011) 1.34
Methods for the analysis of incidence rates in cluster randomized trials. Int J Epidemiol (2002) 1.29
Survival from 9 months of age among HIV-infected and uninfected Zambian children prior to the availability of antiretroviral therapy. Clin Infect Dis (2008) 1.27
Setting research priorities for preconception care in low- and middle-income countries: aiming to reduce maternal and child mortality and morbidity. PLoS Med (2013) 1.26
Medical genetics in developing countries. Annu Rev Genomics Hum Genet (2004) 1.25
Timeline: Raising the profile of genetics in primary care. Nat Rev Genet (2004) 1.24
Collecting genetic information in primary care: evaluating a new family history tool. Fam Pract (2005) 1.23
Impact of counselling on careseeking behaviour in families with sick children: cluster randomised trial in rural India. BMJ (2004) 1.22
Perinatal mortality in rural Burkina Faso: a prospective community-based cohort study. BMC Pregnancy Childbirth (2010) 1.22
Goodstart: a cluster randomised effectiveness trial of an integrated, community-based package for maternal and newborn care, with prevention of mother-to-child transmission of HIV in a South African township. Trop Med Int Health (2014) 1.18
HIV-1 infection in Zambian children impairs the development and avidity maturation of measles virus-specific immunoglobulin G after vaccination and infection. J Infect Dis (2009) 1.17
Morbidity from malaria in children in the year after they had received intermittent preventive treatment of malaria: a randomised trial. PLoS One (2011) 1.16
Safety and efficacy of simplified antibiotic regimens for outpatient treatment of serious infection in neonates and young infants 0-59 days of age in Bangladesh: design of a randomized controlled trial. Pediatr Infect Dis J (2013) 1.13
Does implementation of the IMCI strategy have an impact on child mortality? A retrospective analysis of routine data from Egypt. BMJ Open (2013) 1.10
The effectiveness of birth plans in increasing use of skilled care at delivery and postnatal care in rural Tanzania: a cluster randomised trial. Trop Med Int Health (2013) 1.09
How much time is available for antenatal care consultations? Assessment of the quality of care in rural Tanzania. BMC Pregnancy Childbirth (2011) 1.08
Protection against malaria by MSP3 candidate vaccine. N Engl J Med (2011) 1.08
Satisfactory safety and immunogenicity of MSP3 malaria vaccine candidate in Tanzanian children aged 12-24 months. Malar J (2009) 1.08
Assessment of the uptake of neonatal and young infant referrals by community health workers to public health facilities in an urban informal settlement, KwaZulu-Natal, South Africa. BMC Health Serv Res (2013) 1.07
Simplified antibiotic regimens for the management of clinically diagnosed severe infections in newborns and young infants in first-level facilities in Karachi, Pakistan: study design for an outpatient randomized controlled equivalence trial. Pediatr Infect Dis J (2013) 1.06
Safety and immunogenicity of the malaria vaccine candidate MSP3 long synthetic peptide in 12-24 months-old Burkinabe children. PLoS One (2009) 1.02
Onchocerciasis: the pre-control association between prevalence of palpable nodules and skin microfilariae. PLoS Negl Trop Dis (2013) 1.02
Vitamin a supplementation does not affect infants' immune responses to polio and tetanus vaccines. J Nutr (2005) 1.01
Drawing blood from young children: lessons learned from a trial in Ghana. Trans R Soc Trop Med Hyg (2009) 1.00
Malaria morbidity in children in the year after they had received intermittent preventive treatment of malaria in Mali: a randomized control trial. PLoS One (2011) 0.99
Predicted impact of the HIV-1 epidemic on measles in developing countries: results from a dynamic age-structured model. Int J Epidemiol (2008) 0.99
GPs' opinions of their role in prenatal genetic services: a cross-sectional survey. Fam Pract (2005) 0.97
Measures of between-cluster variability in cluster randomized trials with binary outcomes. Stat Med (2009) 0.96